Altarifi AA, David B, Muchhala KH, Blough BE, Akbarali H, Negus SS (2017) Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents. J Psychopharmacol 31:730–739. https://doi.org/10.1177/0269881116689257

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armendariz A, Nazarian A (2018) Morphine antinociception on thermal sensitivity and place conditioning in male and female rats treated with intraplantar complete freund’s adjuvant. Behav Brain Res 343:21–27. https://doi.org/10.1016/j.bbr.2018.01.031

Article  CAS  PubMed  Google Scholar 

Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495–2498. https://doi.org/10.1126/science.286.5449.2495

Article  CAS  PubMed  Google Scholar 

Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720–723. https://doi.org/10.1038/35047086

Article  CAS  PubMed  Google Scholar 

Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG (2003) Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23:10265–10273. https://doi.org/10.1523/JNEUROSCI.23-32-10265.2003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brust TF, Morgenweck J, Kim SA, Rose JH, Locke JL, Schmid CL et al (2016) Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Sci Signal 9:ra117. https://doi.org/10.1126/scisignal.aai8441

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan HCS, McCarthy D, Li J, Palczewski K, Yuan S (2017) Designing safer analgesics via mu-opioid receptor pathways. Trends Pharmacol Sci 38:1016–1037. https://doi.org/10.1016/j.tips.2017.08.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cornelissen JC, Blough BE, Bohn LM, Negus SS, Banks ML (2021) Some effects of putative G-protein biased mu-opioid receptor agonists in male rhesus monkeys. Behav Pharmacol. https://doi.org/10.1097/FBP.0000000000000634

Article  PubMed  PubMed Central  Google Scholar 

DeWire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM et al (2013) A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther 344:708–717. https://doi.org/10.1124/jpet.112.201616

Article  CAS  PubMed  Google Scholar 

Ding Z, Wang K, Wang B, Zhou N, Li H, Yan B (2016) Efficacy and tolerability of oxycodone versus fentanyl for intravenous patient-controlled analgesia after gastrointestinal laparotomy: a prospective, randomized, double-blind study. Medicine (Baltimore) 95:e4943. https://doi.org/10.1097/MD.0000000000004943

Article  CAS  PubMed  Google Scholar 

Ding H, Kiguchi N, Perrey DA, Nguyen T, Czoty PW, Hsu FC et al (2020) Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates. Br J Anaesth 125:596–604. https://doi.org/10.1016/j.bja.2020.06.057

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gillis A, Gondin AB, Kliewer A, Sanchez J, Lim HD, Alamein C et al (2020) Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Sci Signal. https://doi.org/10.1126/scisignal.aaz3140

Article  PubMed  Google Scholar 

Grim TW, Schmid CL, Stahl EL, Pantouli F, Ho JH, Acevedo-Canabal A et al (2020) A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal. Neuropsychopharmacology 45:416–425. https://doi.org/10.1038/s41386-019-0491-8

Article  CAS  PubMed  Google Scholar 

Gross JL, Pareta AR, Elkassabany NM (2019) Pain management in trauma in the age of the opioid crisis. Anesthesiol Clin 37:79–91. https://doi.org/10.1016/j.anclin.2018.09.010

Article  PubMed  Google Scholar 

Kenakin T (2003) Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol Sci 24:346–354. https://doi.org/10.1016/S0165-6147(03)00167-6

Article  CAS  PubMed  Google Scholar 

Kieffer BL (1999) Opioids: first lessons from knockout mice. Trends Pharmacol Sci 20:19–26. https://doi.org/10.1016/s0165-6147(98)01279-6

Article  CAS  PubMed  Google Scholar 

Kudla L, Bugno R, Skupio U, Wiktorowska L, Solecki W, Wojtas A, Golembiowska K et al (2019) Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine. Br J Pharmacol 176:4434–4445. https://doi.org/10.1111/bph.14805

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kudla L, Bugno R, Podlewska S, Szumiec L, Wiktorowska L, Bojarski AJ, Przewlocki R (2021) Comparison of an addictive potential of μ-opioid receptor agonists with G Protein bias: behavioral and molecular modeling studies. Pharmaceutics 14:55. https://doi.org/10.3390/pharmaceutics14010055

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lacy RT, Strickland JC, Feinstein MA, Robinson AM, Smith MA (2016) The effects of sex, estrous cycle, and social contract on cocaine and heroin self-administration in rats. Psychopharmacology 233:2301–2310. https://doi.org/10.1007/s00213-016-4368-9

Article  CAS  Google Scholar 

Legakis LP, Bigbee JW, Negus SS (2018) Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity. Behav Pharmacol 29:290–298. https://doi.org/10.1097/FBP.0000000000000378

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manglik A, Lin H, Aryal DK, McCorvy JD, Dengler D, Corder G et al (2016) Structure-based discovery of opioid analgesics with reduced side effects. Nature 537:185–190. https://doi.org/10.1038/nature19112

Article  CAS  PubMed  PubMed Central  Google Scholar 

National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington. https://doi.org/10.17226/12910

Pantouli F, Grim TW, Schmid CL, Acevedo-Canabal A, Kennedy NM, Cameron MD et al (2021) Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain. Neuropharmacology 185:108439. https://doi.org/10.1016/j.neuropharm.2020.108439

Article  CAS  PubMed  Google Scholar 

Pascual D, Goicoechea C, Burgos E, Martin MI (2010) Antinociceptive effect of three common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats. Pharmacol Biochem Behav 95:331–337. https://doi.org/10.1016/j.pbb.2010.02.009

Article  CAS  PubMed  Google Scholar 

Pasternak GW, Pan YX (2013) Mu opioids and their receptors: evolution of a concept. Pharmacol Rev 65:1257–1317. https://doi.org/10.1124/pr.112.007138

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pergolizzi JV, LeQuang JA, Taylor R, Ossipov MH, Colucci D, Raffa RB (2018) Designing safer analgesics: a focus on mu-opioid receptor pathways. Expert Opin Drug Discov 13:965–972. https://doi.org/10.1080/17460441

Article  CAS  PubMed  Google Scholar 

Rankovic Z, Brust TF, Bohn LM (2016) Biased agonism: An emerging paradigm in GPCR drug discovery. Bioorg Med Chem Lett 26:241–250. https://doi.org/10.1016/j.bmcl.2015.12.024

Article  CAS